在早期GDM中血糖,血糖变化和怀孕并发症之间的关联
Jincy Immanuel1,2, N Wah Cheung3, Mahta Mohajeri1
1Western Sydney University, Campbelltown, New South Wales, Australia.
Diabetes care
|December 12, 2024
概括
在妊娠糖尿病 (GDM) 中早期的葡萄糖管理改善了整体血糖和怀孕结果. 延迟治疗显示类似于怀孕后期的葡萄糖水平,但较少的最佳血糖控制率.
科学领域:
- 产科和妇科 产科和妇科
- 内分泌学 在内分泌学.
- 围产儿医学 围产儿医学
背景情况:
- 孕期糖尿病 (GDM) 需要及时管理,以优化孕产妇和胎儿的健康.
- 对GDM的早期诊断和干预对于预防并发症至关重要.
研究的目的:
- 检查葡萄糖管理的开始时间如何影响早期GDM妇女的血糖,血糖变异性和怀孕结果.
- 为了比较早期GDM的立即与延迟治疗策略.
主要方法:
- 一项试验的副研究,涉及早期GDM (根据世卫组织2013年标准诊断) 的立即治疗与延迟治疗.
- 参与者每天监测血糖 (BG) 四次 (禁食和食后2小时).
- 最佳血糖是定义为≥95%的BG测量在70-140毫克/dL之间.
主要成果:
- 早期治疗 (n=213) 与延迟治疗 (n=116) 相比,导致平均葡萄糖 (MG) 和平均禁食葡萄糖 (MFG) 的降低.
- 在早期治疗组中,最优的血糖水平更频繁地实现 (74.6%与59.5%相比).
- 总体而言,最佳血糖与较少的孕期大婴儿和较低的孕期体重增加有关.
结论:
- 虽然怀孕后期的血糖在早期和延迟治疗组之间是相似的,但早期干预改善了整体的血糖控制.
- 早期的GDM管理与更好的血糖控制和改善妊娠结果有关.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.2K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.2K
Pathophysiology of Diabetes
866
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
866
Diabetes: Symptoms, Diagnosis, and Complications
504
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
504
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Hypoglycemia and Glucagon
152
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
152
Oral Hypoglycemic Agents: Biguanides and Glitazones
172
Biguanides, particularly metformin (Glucophage), are insulin sensitizers that enhance glucose uptake, thereby reducing insulin resistance. Unlike sulfonylureas, metformin doesn't prompt insulin secretion, which helps to curb hypoglycemia risk. Metformin is beneficial in treating conditions like polycystic ovary syndrome due to its insulin-resistance reduction capability. The drug's primary action involves curtailing hepatic gluconeogenesis, a significant contributor to high blood...
172


